image
Healthcare - Biotechnology - NASDAQ - US
$ 12.7
-9.61 %
$ 83.3 M
Market Cap
-1.12
P/E
BALANCE SHEET
264 M ASSETS
-19.06%
94.1 M LIABILITIES
-5.68%
169 M EQUITY
-24.97%
BALANCE SHEET DECOMPOSITION
Balance Sheet Instil Bio, Inc.
image
Current Assets 124 M
Cash & Short-Term Investments 113 M
Receivables 0
Other Current Assets 11.2 M
Non-Current Assets 139 M
Long-Term Investments 0
PP&E 130 M
Other Non-Current Assets 8.76 M
42.99 %4.23 %49.45 %3.32 %Total Assets$263.6m
Current Liabilities 7.9 M
Accounts Payable 659 K
Short-Term Debt 0
Other Current Liabilities 7.24 M
Non-Current Liabilities 86.2 M
Long-Term Debt 85.2 M
Other Non-Current Liabilities 1.03 M
7.69 %90.52 %Total Liabilities$94.1m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019
ASSETS
Cash & Cash Equivalents 8.8 9.2 43.7 37.6 241.7 8.9
Short Term Investments 104.5 141.2 217.2 416.5 0 0
Receivables 0 0 0 0 3.2 0
Inventory 0 0 0 0 1.2 0
Other Current Assets 1.8 10.4 8.5 19.8 1.3 0.4
Total Current Assets 124.5 160.8 269.4 464.0 246.1 9.3
PP&E 130.3 141.1 209.3 122.0 55.3 0.2
Intangible Assets 0 0 0 10.1 10.1 0
Goodwill 0 0 0 5.7 5.7 0
Long Term Investments 0 23.2 0 0.5 50 K 0
Other Long Term Assets 8.8 0.6 3.4 8.1 1.7 0
Other Assets 0 0 0 0 0 0
Total Assets 263.6 325.6 482.1 610.0 319.0 9.5
LIABILITIES
Accounts Payable 0.7 1.2 2.4 5.6 3.5 1.0
Short Term Debt 0 1.8 2.4 0 0 0
Other Current Liabilities 7.2 7.6 28.0 35.3 9.2 0.4
Total Current Liabilities 7.9 10.6 32.8 41.4 13.3 1.4
Long Term Debt 85.2 84.3 77.5 0 0 0
Deferred Tax Income 0 0 0 2.4 2.5 0
Other Liabilities 1.0 4.9 8.2 11.0 342.9 14.9
Total Liabilities 94.1 99.8 118.5 54.8 358.6 16.4
EQUITY
Common Stock 0 0 0 0 0 0
Retained Earnings (655.1) (581.0) (424.9) (201.7) (44.9) (7.2)
Other Accumulative Comprehensive Income/Loss (0.2) (0.3) (0.5) 87 K (0.3) 0
Total Equity 169.4 225.8 363.6 555.2 (39.6) (6.9)
Total Liabilities and Equity 263.6 325.6 482.1 610.0 319.0 9.5
SHARES OUTSTANDING
Common Shares Outstanding 6.5 6.5 6.5 6.5 6.4 6.4